International Conference on
Nephrology & Urology

This session will highlight advancements in chronic kidney disease (CKD) diagnosis, treatment, and prevention, aiming to improve quality of life and slow progression. Experts will present evidence-based strategies for risk control, patient education, and personalized care. Key topics include novel biomarkers for early detection, emerging therapies for inflammation and fibrosis, and the vital role of multidisciplinary teams. Attendees will explore real-world case studies, learn ways to boost adherence to lifestyle and medication plans, and discover how digital health tools—such as remote monitoring and AI models—can optimize decisions, reduce hospitalizations, and enhance CKD management across diverse healthcare settings.

Kidney transplantation remains the gold standard for end-stage renal disease, and innovations are transforming outcomes. This session will highlight donor organ preservation through hypothermic and normothermic perfusion techniques, reducing ischemia-reperfusion injury and improving graft viability. Advances in immunosuppression and tolerance induction strategies will be discussed, emphasizing safer, more personalized regimens. Expanding the donor pool via paired kidney exchange, living donor programs, and extended-criteria organs will also be explored. Post-transplant monitoring tools, including molecular diagnostics and precision medicine, offer earlier rejection detection and improved long-term care. Ethical considerations, patient counseling, and survivorship planning will provide a holistic perspective. Whether you are a surgeon, nephrologist, or allied health professional, this session will deliver actionable insights to optimize transplant outcomes.

Precision medicine is reshaping kidney and urinary tract care through genetic profiling, molecular diagnostics, and advanced imaging. This session will explore tailored therapies for glomerular diseases, polycystic kidney disease, and urothelial cancers, emphasizing breakthroughs in disease subtyping and targeted treatments. Experts will highlight pharmacogenomics for optimizing drug efficacy while reducing adverse effects. Artificial intelligence and machine learning applications in predicting disease progression and surgical planning will be showcased, alongside real-world case studies. Practical challenges such as accessibility, cost, and ethical considerations will also be addressed. Participants will gain strategies to integrate precision medicine into practice, improving individualized care and patient outcomes.

Artificial intelligence (AI) is revolutionizing nephrology and urology, enabling faster and more accurate diagnosis and treatment planning. This session will cover predictive analytics for acute kidney injury, AI-powered image analysis for kidney stones and bladder tumors, and enhanced pathology interpretation. Attendees will explore how AI is improving transplant organ matching, robotic-assisted surgery, and post-operative monitoring. Presenters will address integration challenges, algorithmic bias, and regulatory requirements to ensure safe adoption. Real-world applications will demonstrate AI’s impact on predicting complications, personalizing care, and streamlining workflows. By the end, participants will understand how to implement AI responsibly for better patient care and clinical efficiency.

Dialysis technology is evolving rapidly, offering patients safer and more effective treatments. This session will examine innovations in hemodialysis and peritoneal dialysis, including wearable and portable devices that enhance mobility and independence. New membrane materials designed to improve toxin clearance while minimizing inflammation will be discussed, alongside advances in ultrafiltration control for better stability. Remote monitoring tools that track patient health between sessions will be highlighted, reducing risks and hospitalizations. The session will also explore regenerative medicine approaches and the potential of bioartificial kidneys as future alternatives. Practical aspects such as vascular access optimization, infection prevention, and patient education will round out the discussion, equipping attendees with strategies to improve dialysis outcomes.

Children with kidney and urinary tract disorders require specialized approaches. This session will focus on congenital anomalies, vesicoureteral reflux, nephrotic syndrome, and pediatric kidney stones. Advances in prenatal diagnosis, early intervention, and minimally invasive surgery will be discussed, emphasizing strategies to prevent long-term complications. The importance of multidisciplinary care—bringing together nephrologists, urologists, dietitians, and psychologists—will be highlighted to address growth, nutrition, and psychosocial needs. Attendees will also learn best practices for managing pediatric chronic kidney disease, including family-centered care and education. The session will prepare participants to deliver effective, compassionate care to children living with these conditions.

Minimally invasive techniques are transforming urology by offering faster recovery, less pain, and improved outcomes. This session will explore laparoscopic and robotic-assisted approaches for prostate cancer, kidney tumors, and ureteral conditions. Experts will highlight innovations such as 3D imaging, advanced instrumentation, and intraoperative navigation systems that enhance precision. Patient selection, surgical planning, and training considerations will also be addressed, along with cost-effectiveness and adoption challenges in resource-limited settings. Real-world case studies will illustrate how these techniques achieve strong oncologic and functional results. Attendees will gain practical insights into integrating minimally invasive surgery into urological practice.

Biomarkers are emerging as vital tools for early detection and monitoring in nephrology and urology. This session will examine molecular, proteomic, and metabolomic biomarkers for acute kidney injury, bladder cancer, and glomerulonephritis. Presenters will compare biomarker-based diagnostics with conventional methods, highlighting improved sensitivity and potential for non-invasive testing. Attendees will learn about commercially available assays, ongoing clinical trials, and integration with imaging and clinical parameters to guide personalized treatment. Challenges in cost, standardization, and regulatory approval will also be discussed. The session will provide clinicians and researchers with actionable insights for incorporating biomarkers into routine care.

Kidney stones require comprehensive management strategies. This session will cover prevention approaches through diet, hydration, and pharmacologic therapies, tailored to stone type and patient risk. Attendees will explore diagnostic imaging advances and minimally invasive interventions such as ureteroscopy, laser lithotripsy, and percutaneous nephrolithotomy. Presenters will also address metabolic evaluations, genetic profiling, and long-term monitoring via telemedicine. Special focus will be given to complex cases like staghorn calculi and stones in anatomically challenging kidneys. Participants will leave with evidence-based tools to prevent recurrence, improve patient safety, and optimize stone management outcomes.

Hypertension is both a cause and effect of kidney disease, making its management essential. This session will review the latest guidelines for controlling blood pressure in chronic kidney disease, diabetic nephropathy, and post-transplant patients. Topics will include ambulatory blood pressure monitoring, new antihypertensive medications, and tailored combination therapies. Lifestyle strategies such as sodium restriction, weight control, and exercise will also be emphasized. Attendees will learn to diagnose and manage secondary causes of hypertension, including renovascular disease and endocrine disorders. Patient education, adherence, and equitable access to care will be highlighted, equipping participants with practical approaches to protect kidney function and reduce cardiovascular risk.

Acute kidney injury is a serious complication that requires timely recognition and intervention. This session will cover the latest KDIGO guidelines, novel biomarkers for early diagnosis, and hemodynamic optimization to prevent disease progression. Case-based discussions will explore AKI in sepsis, surgery, and multi-organ failure scenarios. Experts will share strategies for managing AKI in intensive care settings, highlighting the importance of collaboration between nephrologists, intensivists, and nursing teams. Emerging therapies, such as extracorporeal blood purification, will also be discussed. By the end, participants will gain a clear framework for identifying and managing AKI effectively across diverse clinical settings.

Autoimmune diseases such as lupus nephritis, IgA nephropathy, and vasculitis present complex care challenges. This session will discuss advances in understanding disease mechanisms and how they inform new therapies. Emerging immunosuppressive agents, biologics, and combination regimens will be reviewed with a focus on balancing safety and efficacy. Practical insights into disease monitoring, flare prevention, and management of treatment side effects will be shared. Case presentations will illustrate strategies for refractory cases and long-term care. Emphasis will also be placed on multidisciplinary collaboration between nephrology, rheumatology, and patient support services.

This session will address the unique challenges of female urology, including urinary incontinence, pelvic floor dysfunction, and recurrent urinary tract infections. Diagnostic tools such as urodynamics and pelvic imaging will be discussed, along with minimally invasive procedures like mid-urethral sling surgery and robotic reconstruction. Presenters will also cover the impact of pregnancy, menopause, and hormonal changes on urinary health. Patient-centered care and quality-of-life considerations will be emphasized through case-based discussions. Attendees will gain practical approaches to delivering comprehensive and compassionate care for women with urological conditions.

Nutrition plays a central role in managing kidney disease and improving outcomes. This session will focus on dietary strategies for chronic kidney disease, dialysis, and transplant patients. Experts will discuss protein, electrolyte, and fluid management, along with interventions for hyperkalemia, hyperphosphatemia, and metabolic acidosis. The benefits of plant-based diets, keto-analogues, and micronutrient supplementation will be highlighted. Attendees will learn approaches for individualized and culturally sensitive counseling, integrating nutrition into multidisciplinary care. Patient education tools and resources will be shared to enhance dietary adherence and improve overall kidney health.